Watch for Lerodalcibep, A New Med for High Cholesterol

July 2026

Rx lerodalcibep (Lerochol) will be a new injectable med to lower high cholesterol.

It joins alirocumab (Praluent), evolocumab (Repatha), and inclisiran (Leqvio) as the fourth PCSK9 inhibitor.

These meds work a little differently to impact PCSK9 (a protein in the liver)...but ultimately, they help clear LDL cholesterol (LDL-C) or bad cholesterol from the blood.

Practical advice for a better career, with unlimited access to CE

Pharmacy Technician's Letter includes:

12 issues every year, with brief articles about new meds and hot topics
120+ CE courses, including the popular CE-in-the-Letter
Helpful, in-depth Technician Tutorials
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get a quote

GLP-1 Agonists Navigate Questions About the Medicare GLP-1 Bridge
Lyme Disease Brush Up on Tick Bites and Preventing Lyme Disease
Rumor vs Truth Listen for Common Claims About Laxatives and Constipation
Laws & Regulations Be Ready for an Expanding Tech Scope of Practice
Ophthalmology Sharpen Focus on Rx Presbyopia Eye Drops
Controlled Substances Your Complete Guide to Controlled Substance Rx Validation
Cholesterol Watch for Lerodalcibep, A New Med for High Cholesterol
Stroke Look for Antiplatelet Meds to Help Prevent Another Stroke

Watch for Lerodalcibep, A New Med for High Cholesterol

Practical advice for a better career, with unlimited access to CE

Table of Contents